Data / Drug companies / Lamivudine
Lamivudine: 14 companies and 27 products in the FDA NDC directory
Lamivudine is listed in the FDA National Drug Code Directory by 14 companies, with 27 products in commercial distribution. 24 of the products (88.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; solution; tablet, and the newest product started marketing on February 6, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 14
- Products
- 27
- Generic (ANDA) products
- 24 (88.9%)
- Application numbers
- 13
- Routes
- Oral
- Brand names
- Epivir
- openFDA record search
- api.fda.gov
Companies that list lamivudine
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Camber Pharmaceuticals, Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | March 21, 2019 |
| Apotex Corp. | 3 | tablet, film coated | Generic drugs (ANDA) | January 3, 2014 |
| Aurobindo Pharma Limited | 3 | tablet, film coated; solution | Generic drugs (ANDA) | November 21, 2016 |
| ViiV Healthcare Company | 3 | tablet, film coated; solution | New drug applications (NDA) | October 4, 2010 |
| Golden State Medical Supply, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | December 2, 2011 |
| Ingenus Pharmaceuticals, LLC | 2 | tablet | Generic drugs (ANDA) | February 1, 2017 |
| Macleods Pharmaceuticals Limited | 2 | tablet, film coated | Generic drugs (ANDA) | May 2, 2019 |
| Strides Pharma Science Limited | 2 | tablet, film coated | Generic drugs (ANDA) | October 19, 2018 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | January 19, 2023 |
| Coupler LLC | 1 | tablet, film coated | Generic drugs (ANDA) | February 6, 2025 |
| Golden State Medical Supply, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | January 2, 2014 |
| Lupin Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | March 25, 2015 |
| Major Pharmaceuticals | 1 | tablet, film coated | Generic drugs (ANDA) | December 2, 2011 |
| Rising Pharma Holdings, Inc. | 1 | solution | Generic drugs (ANDA) | November 21, 2016 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 22 | 81.5% |
| Solution | 3 | 11.1% |
| Tablet | 2 | 7.4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 24 | 88.9% |
| New drug applications (NDA) | 3 | 11.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor | 27 |
| Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor | 27 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.